These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 5112575)

  • 1. A synthetic iodinated polypeptide that inhibits polymerization of fibrinogen.
    Miale JB; Mende TJ
    Blut; 1971; 22(2):76-9. PubMed ID: 5112575
    [No Abstract]   [Full Text] [Related]  

  • 2. Amino acids and peptides. XVI. Synthesis of N-terminal tetrapeptide analogs of fibrin alpha-chain and their inhibitory effects on fibrinogen/thrombin clotting.
    Kawasaki K; Hirase K; Miyano M; Tsuji T; Iwamoto M
    Chem Pharm Bull (Tokyo); 1992 Dec; 40(12):3253-60. PubMed ID: 1294328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in spontaneous fibrinolytic activity during use of oral contraceptives.
    Hedlin AM; Monkhouse FC
    Obstet Gynecol; 1971 Feb; 37(2):225-32. PubMed ID: 5539358
    [No Abstract]   [Full Text] [Related]  

  • 4. Anticoagulant activity of original synthetic peptide derivatives.
    Drozd NN; Tolstenkov AS; Makarov VA; Miphtakhova NT; Voyushina TL; Sergeev ME
    Bull Exp Biol Med; 2008 Jan; 145(1):51-4. PubMed ID: 19024001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Shortening of Howell's time in plasma incubated with streptokinase].
    Baggio P; Gravina E; Bonifaci E
    Boll Soc Ital Biol Sper; 1967 Dec; 43(24):1815-9. PubMed ID: 5601962
    [No Abstract]   [Full Text] [Related]  

  • 6. Anticoagulant activity of synthetic iodinated polypeptides.
    Mende TJ
    Pharmacology; 1970; 4(5):309-15. PubMed ID: 5490477
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antiheparin properties of synthetic polycations].
    Dubovik VV; Etlis VS; Baluda VP; Sushkevich GN; Shevchuk AS
    Farmakol Toksikol; 1975; 38(2):193-8. PubMed ID: 1227887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of oligomer cations on blood coagulation].
    Herre V; Frimmer M
    Thromb Diath Haemorrh; 1968 Nov; 20(1):227-33. PubMed ID: 5751382
    [No Abstract]   [Full Text] [Related]  

  • 9. Some inhibitors of the fibrinogen-fibrin conversion.
    Elias TP; Iyer GY
    Thromb Diath Haemorrh; 1967 Dec; 18(3-4):499-509. PubMed ID: 4968852
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on the mechanism of action of inhibitors of the fibrinolysin system.
    Ambrus CM; Ambrus JL; Lassman HB; Mink IB
    Ann N Y Acad Sci; 1968 Jun; 146(2):430-47. PubMed ID: 4239437
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of fibrinolytic inhibitors and heparin on induced intravascular coagulation.
    Nordström S
    Acta Physiol Scand Suppl; 1970; 337():1-35. PubMed ID: 5311663
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of Ancrod (Arvin) in mice: studies of plasma fibrinogen and fibrinolytic activity.
    Silberman S; Bernik MB; Potter EV; Kwaan HC
    Br J Haematol; 1973 Jan; 24(1):101-13. PubMed ID: 4197581
    [No Abstract]   [Full Text] [Related]  

  • 13. Peptides and pseudopeptides incorporating D-Phe-Pro-Arg and Arg-Gly-Asp lead sequences as potential antithrombotic agents.
    Ilas J; Hudecz F; Süli-Vargha H; Kikelj D
    J Pept Sci; 2008 Aug; 14(8):946-53. PubMed ID: 18383437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioiodinated human fibrinogen. In vitro effects of increasing iodination.
    Ly B; Kierulf P
    Thromb Res; 1975 May; 6(5):387-98. PubMed ID: 237338
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effects of iodine on the blood coagulation, anticoagulation and fibrinolytic systems in patients with atherosclerosis].
    Shershevskiĭ MG; Rassokhin VM
    Kardiologiia; 1966; 6(1):74-7. PubMed ID: 5970414
    [No Abstract]   [Full Text] [Related]  

  • 16. Measurement of fibrinopeptide A in human blood.
    Nossel HL; Yudelman I; Canfield RE; Butler VP; Spanondis K; Wilner GD; Qureshi GD
    J Clin Invest; 1974 Jul; 54(1):43-53. PubMed ID: 4600045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amino acids and peptides. XVIII. Synthetic peptides related to N-terminal portion of fibrin alpha-chain and their inhibitory effect on fibrinogen/thrombin clotting.
    Kawasaki K; Miyano M; Hirase K; Iwamoto M
    Chem Pharm Bull (Tokyo); 1993 May; 41(5):975-7. PubMed ID: 8339344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulant and thrombolytic drugs. I. Patho-physiological and pharmacological aspects.
    Ogston D; Douglas AS
    Drugs; 1971; 1(3):228-46. PubMed ID: 4256645
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of fibrin polymerization inhibitors on quantitative measurements of plasma fibrinogen.
    Hoffman M; Greenberg CS
    Am J Clin Pathol; 1987 Oct; 88(4):490-3. PubMed ID: 3661500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amino acids and peptides. XVII. Synthesis of peptides related to N-terminal portion of fibrin alpha-chain and their inhibitory effect on fibrinogen/thrombin clotting.
    Kawasaki K; Tsuji T; Hirase K; Miyano M; Inouye S; Iwamoto M
    Chem Pharm Bull (Tokyo); 1993 Mar; 41(3):525-8. PubMed ID: 8477503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.